dendritic cell vaccine (Cristal Therapeutics/PX Biosolutions)

N/A

Report date: 2025/01/26 17:34:17

Base Information

Drug Namedendritic cell vaccine (Cristal Therapeutics/PX Biosolutions)

Drug Alias NameN/A

ClassificationBiologics > Antigen > Tumor antigenCell and gene therapy > Cell therapyVaccines > Development/production technology > Dendritic cell vaccine +[4]

Mechanisms of ActionCoronavirus spike glycoprotein modulators

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesNetherlandsAustralia and New Zealand

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCristal Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesCristal Therapeutics

Inactive CompaniesPx Biosolutions

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A